Immunoproteasome inhibitor 1

• CAT Number: I043885
• CAS Number: 2755772-63-3
• Molecular Formula: C20H26N2O4
• Molecular Weight: 358.43
• Purity: ≥95%
• Synonyms: (E)-4-(6,7-dimethoxy-1-oxoisoquinolin-2-yl)-N-(3-methylbutyl)but-2-enamide
• InChI: InChI=1S/C20H26N2O4/c1-14(2)7-9-21-19(23)6-5-10-22-11-8-15-12-17(25-3)18(26-4)13-16(15)20(22)24/h5-6,8,11-14H,7,9-10H2,1-4H3,(H,21,23)/b6-5+
• InChIKey: OLDBMIBYBKUNPK-AATRIKPKSA-N
• SMILES: CC(C)CCNC(=O)/C=C/CN1C=CC2=CC(=C(C=C2C1=O)OC)OC

Immunoproteasome Inhibitor 1（Cat No.:I043885）is a small molecule compound designed to selectively target and inhibit the immunoproteasome, a specialized form of the proteasome involved in regulating immune responses. By disrupting the immunoproteasome’s activity, this inhibitor affects the degradation of key signaling molecules and alters immune cell function. It has potential therapeutic applications in autoimmune diseases, inflammation, and cancer, as it can modulate the immune system and tumor microenvironment. Immunoproteasome Inhibitor 1 is valuable for research into immune regulation and as a potential lead for developing targeted therapies in immunology and oncology.